World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
26229
World Ranking
12783
National Ranking
487

Overview

Alberto Bosi is affiliated with the University of Florence in Italy and has authored numerous publications primarily in the field of Medicine, with a focus on hematology and related disciplines. Their research encompasses key areas such as hematology, genetics, oncology, molecular biology, and pathology and forensic medicine.

Their main topics of study include:

  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Protein Degradation and Inhibitors

Alberto Bosi has published research in several frequently appearing scientific venues such as:

  • European Journal Of Haematology
  • Blood
  • Leukemia
  • Cancers
  • American Journal of Hematology

Some recent papers attributed to the scientific community around this field include:

  • "Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study" (2020), Leukemia
  • "Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study" (2020), Leukemia
  • "Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study" (2020), The Lancet Haematology
  • "Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk" (2020), Journal of Hematology & Oncology
  • "One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab" (2020), European Journal Of Haematology

Frequent co-authors collaborating with Alberto Bosi include:

  • Francesco Mannelli
  • Giacomo Gianfaldoni
  • Benedetta Puccini
  • Monica Bocchia
  • Alessandro M. Vannucchi

Best Publications

  • Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

    Vanderson Rocha;Myriam Labopin;Guillermo Sanz;William Arcese

  • Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Rambaldi

  • Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

    Andrea Bacigalupo;Teresa Lamparelli;Paolo Bruzzi;Stefano Guidi

  • Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    H Miles Prince;H Miles Prince;Youn H Kim;Steven M Horwitz;Reinhard Dummer

  • Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

    Renato Bassan;Orietta Spinelli;Elena Oldani;Tamara Intermesoli

  • Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

    Enric Carreras;Hartmut Bertz;William Arcese;Jean-Paul Vernant

  • Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia

    Giada Rotunno;Carmela Mannarelli;Paola Guglielmelli;Annalisa Pacilli

  • Prospective identification of high-risk polycythemia vera patients based on JAK2 V617F allele burden

    Alessandro Maria Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;G. Longo

  • Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

    Andrea Bacigalupo;Teresa Lamparelli;Giovanni Barisione;Paolo Bruzzi

  • Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

    Francesco Lo-Coco;Giuseppe Avvisati;Marco Vignetti;Massimo Breccia

  • Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

    P Ljungman;P Ribaud;M Eyrich;S Matthes-Martin

  • The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease

    Andrea Gallamini;Luigi Rigacci;Francesco Merli;Luca Nassi

  • The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Joannah Score

  • Clinical implications of the JAK2 V617F mutation in essential thrombocythemia

    E Antonioli;P Guglielmelli;A Pancrazzi;C Bogani

  • Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone : a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation

    M T Van Lint;C Uderzo;A Locasciulli;I Majolino

  • Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Pancrazzi

  • EZH2 mutational status predicts poor survival in myelofibrosis

    Paola Guglielmelli;Flavia Biamonte;Joannah Score;Joannah Score;Claire Hidalgo-Curtis;Claire Hidalgo-Curtis

  • Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele.

    Paola Guglielmelli;Giovanni Barosi;Giorgina Specchia;Alessandro Rambaldi

  • Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR.

    Andrew Spencer;Suzanne Lentzsch;Katja Weisel;Hervé Avet-Loiseau

  • WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: A study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

    Emilio Paolo Alessandrino;Matteo Giovanni Della Porta;Andrea Bacigalupo;Maria Teresa Van Lint

Frequent Co-Authors

Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Paola Guglielmelli
Paola Guglielmelli University of Florence
Paolo Corradini
Paolo Corradini University of Milan
Andrea Bacigalupo
Andrea Bacigalupo Catholic University of the Sacred Heart
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Giovanni Barosi
Giovanni Barosi University of Pavia
Giorgina Specchia
Giorgina Specchia University of Bari Aldo Moro
Myriam Labopin
Myriam Labopin Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in Medicine goes beyond traditional medical school pathways. A variety of online degree options make it possible for students and professionals to enter or advance within the healthcare industry from anywhere.

Those interested in the management side of healthcare can pursue healthcare administration programs. These degrees prepare graduates for leadership roles in hospitals, clinics, and public health organizations.

Registered Nurses aiming to become Family Nurse Practitioners may consider specialized rn to fnp bridge programs. These online programs help nurses expand their clinical scope without putting their careers on hold.

There is also strong demand for experts in nutrition, with flexible online nutrition degree programs available for students interested in dietetics, wellness, or public health nutrition.

For those aspiring to executive-level positions, online mha programs provide accredited pathways to versatile and influential careers leading major healthcare institutions.

Best Scientists Citing Alberto Bosi

Trending Scientists

Recently Published Articles